BioHealth News
And the Galien Foundation Winners are …
To kick off the new year, The Galien Foundation is delighted to share with you highlights from the 2022 Prix Galien Awards Ceremony and…
Read More
Global biopharmaceutical company expands in Maryland
Kite , a global biopharmaceutical company, is adding 100 new jobs and expanding its cell therapy manufacturing operations in Frederick County. A Gilead company, Kite…
Read More
Linshom Medical raising $3M series A to launch respiratory monitor
Linshom Medical raising $3M series A to launch respiratory monitor Ellicott City startup Linshom Medical is looking to raise a $3 million round as…
Read More
HighTide-HighTide Therapeutics Raises $107 Million in Series C/C+ Financing to Advance Innovative Pipeline and Business Collaborations
· Global biopharmaceutical company focusing on metabolic and digestive diseases · Proceeds to fund clinical and business development ROCKVILLE, MD and SHENZHEN, CHINA,January 5, 2023— HighTide…
Read More
Significant Changes to the SBIR and STTR Programs
On September 30, 2022, the SBIR and STTR Extension Act of 2022 (the Act) was enacted, reauthorizing the SBIR and STTR programs until September…
Read More
CinCor Pharma to be Acquired by AstraZeneca
WALTHAM, Mass., Jan. 09, 2023 (GLOBE NEWSWIRE) -- CinCor Pharma, Inc. (NASDAQ: CINC) today announced that it has entered into a definitive agreement with…
Read MoreGaithersburg’s Novavax names John Jacobs as new CEO – Washington Business Journal
The transition will take place in late January. Image: Stanley Erck is retiring as CEO of Gaithersburg vaccine maker Novavax. EMAN MOHAMMED {iframe}https://www.bizjournals.com/washington/news/2023/01/09/novavax-stanley-erck-john-jacobs-ceo-covid-vaccine.html?utm_source=st&utm_medium=en&utm_campaign=BN&utm_content=wa&ana=e_wa_BN&j=30194551&senddate=2023-01-09{/iframe}
Read More
AstraZeneca to Aquire CinCor Pharma, Inc
Today we announced an agreement to acquire CinCor Pharma, Inc., a US-based clinical-stage biopharmaceutical company, focused on developing novel treatments for resistant and uncontrolled…
Read More
Qiagen acquires DNA-biometrics firm Verogen in $150 mln deal
Jan 9 (Reuters) - Life sciences firm Qiagen said on Monday it has acquired DNA-biometrics firm Verogen in a $150-million cash deal, strengthening its…
Read More
Technology as a New Evolution in Fighting Disease
Scientists and researchers have made remarkable breakthroughs in basic science to better understand the complex pathology of many diseases today. Some of that progress…
Read More
NIH-Oxford Scholar Sooraj Achar Honored with BioHealth Innovation Award – International Biomedical Alliance
First awarded in 2016, the International Biomedical Research Alliance’s Innovation Award recognizes novel solutions in biology or medicine and acknowledges discoveries of unusual importance,…
Read More
Emergent BioSolutions Awarded $379.6 Million Procurement Contract to Supply RSDL© (Reactive Skin Decontamination Lotion Kit) to U.S. Department of Defense
GAITHERSBURG, Md., Jan. 05, 2023 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE:EBS) today announced that it has signed an indefinite-delivery, indefinite-quantity procurement contract with a…
Read More
Who were the biggest employers in Maryland last year?
Maryland, with its six million plus residents, may not be the biggest state, but even before the creation of the United States, the colony’s…
Read More
What’s next for mRNA vaccines | MIT Technology Review
Cast your mind back to 2020, if you can bear it. As the year progressed, so did the impact of covid-19. We were warned…
Read More
WuXi Biologics and GSK Enter into License Agreement on Multiple Novel Bi- & Multi-specific T Cell Engagers
SHANGHAI, Jan. 4, 2023 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269. HK), a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), today announced…
Read More